The Norwegian government aims to double the number of clinical trials within 2025 and make trials an integrated part of treatments. A very positive plan, LMI CEO, Karita Bekkemellem, says.
The corona pandemic continues, as do the limitations of external monitoring visits to hospitals in connection with clinical trials.
LMI har gjort betydelige endringer i bransjereglene. Se video der LMIs Ramona Melanie Eichenberger forteller om de viktigste endringene.